Comparing Cognitive Behavioral Therapy and Brief Behavioral Therapy for Insomnia in Military Members with Mild Traumatic Brain Injury and Postconcussive Symptoms
Led by The University of Texas Health Science Center at San Antonio · Updated on 2026-01-07
160
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the best behavioral treatment for insomnia in active duty service members who have both insomnia and prolonged postconcussive symptoms lasting at least three months after a mild traumatic brain injury mTBI. This study compares Cognitive Behavioral Therapy for Insomnia CBT-I with Brief Behavioral Therapy for Insomnia BBT-I to see how each affects insomnia severity and related postconcussive symptoms. The research also investigates the impact on blood-based biomarkers to better understand treatment effects.
Participants will receive either six weekly 50-minute sessions of CBT-I or four weekly 30-minute sessions of BBT-I, both delivered individually by trained behavioral health providers. Treatments can be given in person or through telehealth to fit participants schedules. Completion requires attending at least four CBT-I sessions or three BBT-I sessions, along with baseline, 7-week, and 12-week follow-up assessments.
During the study, participants will undergo evaluations that include the Insomnia Severity Index, Neurobehavioral Symptom Inventory, and NIH Toolbox assessments at baseline and follow-ups. Additional questionnaires will assess sleep beliefs, nightmares, sleepiness, mood, fatigue, headache impact, anxiety, and suicidality. The study lasts about 12 weeks, with monitoring to track changes in symptoms and treatment effects.
CONDITIONS
Brief Title
Behavioral Insomnia Treatment in Mild Traumatic Brain Injury
Research Team
I
Isabella McElwain, B.S.
K
Kristi E. Pruiksma, Ph.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
The University of Texas Health Science Center at San Antonio
Lead Sponsor
Congressionally Directed Medical Research Programs
Collaborating Sponsor
How This Trial Compares With Other Options
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
CBT‑I (standard behavioral insomnia therapy)
BBTI (brief behavioral insomnia therapy)
What it is
A structured behavioral therapy delivered over six weekly individual sessions (50 minutes each), in person or via telehealth, by a trained provider.
A shorter behavioral therapy delivered over four weekly individual sessions (30 minutes each), in person or via telehealth, by a trained provider.
Role in the trial
One of two randomized treatment arms being evaluated for mild TBI‑related chronic insomnia.
The other randomized treatment arm serving as a briefer behavioral insomnia option.
Primary use
To treat chronic insomnia following mild traumatic brain injury in active duty military service members.
To treat chronic insomnia following mild traumatic brain injury in active duty military service members, using fewer and shorter sessions.
How it is given or performed
Delivered individually in six weekly 50‑minute sessions via in‑person or telehealth.
Delivered individually in four weekly 30‑minute sessions via in‑person or telehealth.
Evidence in broader context
CBT‑I is strongly recommended as first‑line treatment for chronic insomnia in VA/DoD guidelines.
BBTI is supported by weaker recommendations as a briefer behavioral alternative for chronic insomnia.
Important limitations
Requires more time commitment and provider access; six longer sessions may pose barriers.
Shorter format may be less effective for some patients; long‑term durability of benefit may be less established.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years - 45Years
All Genders
Eligibility Criteria
You may qualify if you...
Active duty U.S. military service members
At least 18 years of age and no older than 45 years
Ability to provide informed consent and follow study-related instructions
Self-report of mild traumatic brain injury at least 3 months prior to enrollment
At least 2 postconcussive symptoms scored greater than 2 on the Neurobehavioral Symptom Inventory, including at least 1 cognitive symptom and sleep disturbances
Clinically significant chronic insomnia disorder confirmed by independent evaluator
Minimum score of 15 on the Insomnia Severity Index
Plans to remain in the area for the next 3 months
Stable on psychotropic and hypnotic medications for at least 1 month
Stable on continuous positive airway pressure therapy for sleep apnea for at least 1 month
You will not qualify if you...
Moderate traumatic brain injury such as skull fracture or brain hemorrhage
Any urgent sleep, medical, or psychiatric disorder interfering with baseline assessment or requiring urgent treatment
Working night shifts more than 3 times per month
Planned major surgery during the study period
Pregnancy confirmed by self-report and medical records
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or telehealth)
Outpatient Treatment
Duration - 4 to 6 weeks depending on therapy assigned
Participants receive behavioral therapy sessions for insomnia either through Cognitive Behavioral Therapy for Insomnia (6 weekly sessions) or Brief Behavioral Therapy for Insomnia (4 weekly sessions), delivered individually by a trained provider in-person or via telehealth.
Weekly visits for 4 to 6 weeks
Follow-up
Duration - Up to 12 weeks after baseline assessment
Participants complete follow-up assessments to evaluate insomnia symptom severity and postconcussive symptoms at 7 weeks and 12 weeks after baseline.
2 follow-up visits (in-person or telehealth)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Study of 40 Hz Flicker Light Therapy for Insomnia and Sleep Problems in Parkinsons Disease Patients Aged 50 to 75
Study of Lemborexant Versus Placebo to Reduce Brain Biomarkers in Adults Aged 40-65 With Insomnia Disorder
Comparing Tele-Brief Behavioral Treatment and Tele-Cognitive-Behavioral Therapy for Insomnia in Socioeconomically Disadvantaged Adults in Primary Care
Observational Study Evaluating Lemborexant for Insomnia in Adults With Psychiatric Disorders
Study Comparing Inhaled and Oral Melatonin for Treating Insomnia in Adults Aged 55 and Older
Comparing Common Prescription and Over-the-Counter Medications for Insomnia Treatment in Adults Using a Sequential Randomized Trial Design
Evaluating a Stepped Care Approach to Deliver Cognitive Behavioral Therapy for Insomnia in Adults Aged 18 to 70 in Community Settings
Improving Sleep and Reducing Sedentary Time in Adults with Type 2 Diabetes
A 12-Week Study Using CBTi and Behavior Change Support
Evaluating Suvorexant for Insomnia in Adults With Opioid Use Disorder A Randomized, Placebo-Controlled Phase 3 Study
Randomized Trial of Accelerated Behavioral Therapies Combining Cognitive-Behavioral and Written Exposure Treatments for Military-Related Insomnia, Nightmares, and PTSD
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea: Synopsis of the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines.
Vincent Mysliwiec, Jennifer L Martin, Christi S Ulmer...
Brief Behavioral Treatment for Insomnia vs. Cognitive Behavioral Therapy for Insomnia: Results of a Randomized Noninferiority Clinical Trial Among Veterans.